BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28

• Business

  BioAmber Announces CFO Transition

  April 3, 2017

   · 

  2 min read
• Drug Development

  Data On Verastem’s Focal Adhesion Kinase Inhibitor Defactinib Presented At The 2017 AACR Annual Meeting

  April 3, 2017

   · 

  7 min read
• Angle: Parsortix Enables Analysis In Head And Neck Cancer

  April 3, 2017

   · 

  5 min read
• Drug Development

  Phase II Data Show Bayer’s Investigational Compound Copanlisib Achieved Durable Tumor Response In Indolent Non-Hodgkin’s Lymphoma

  April 3, 2017

   · 

  8 min read
• Deals

  Syneron Candela Rockets After $397 Million Buyout Deal With Apax Partners

  April 3, 2017

   · 

  7 min read
• Drug Development

  BioDirection Announces Results From Pre-Clinical Study Of Tbit System For Detection Of Traumatic Brain Injury

  April 3, 2017

   · 

  3 min read
• Pharm Country

  NYU Langone Medical Center Release: New Gene-Based Blood Tests Identify More Skin Cancers

  April 3, 2017

   · 

  4 min read
• Drug Development

  Ascendis Showcases New Data On Rare Disease Product Pipeline At ENDO 2017

  April 3, 2017

   · 

  9 min read
• Drug Development

  Genprex Reports New Pre-Clinical Data Showing Strong Anti-Tumor Effect Of TUSC2 In Combination With PD-1 Checkpoint Blockade In Lung Cancer

  April 3, 2017

   · 

  5 min read
• Drug Development

  Madrigal Reports 2016 Fourth Quarter And Year-End Financial Results, Reviews Key Corporate Achievements And Provides Update On Lead Clinical-Stage Compound, MGL-3196

  April 3, 2017

   · 

  1 min read